Kim Jong Joseph 4

4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 1, 2022

Form 4

Period: 2022-02-26

DirectorChief Executive Officer10% Owner

Transactions

Exercise/Conversion
Restricted Stock Unit
2022-02-26−68,767→ 137,533 total
→ Common Stock (68,767 underlying)
Award
Common Stock Option
2022-02-26+627,700→ 627,700 total
Exercise: $3.22From: 2022-02-26Exp: 2032-02-26→ Common Stock (627,700 underlying)
Award
Restricted Stock Unit
2022-02-26+468,500→ 468,500 total
→ Common Stock (468,500 underlying)
Exercise/Conversion
Common Stock
2022-02-26+68,767→ 1,297,425 total
Tax Payment
Common Stock
2022-02-26$3.22/sh−20,045$64,545→ 1,277,380 total

Holdings

Footnotes (4)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
[F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
[F3]The vesting schedule for the 627,700 options is as follows: 156,925 shares vested on February 26, 2022; 156,925 shares will vest on February 26, 2023; 156,925 shares will vest on February 26, 2024; 156,925 shares will vest on February 26, 2025.
[F4]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.

Documents

1 file